Q4 2015 Holdings
Filed 2016-02-16 | 88 holdings | $88.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biodel Inc | COM NEW | 09064M204 | $685 | 2,000,000 | 0.0% |
| Palatin Technologies Inc | COM PAR $ .01 | 696077403 | $908 | 1,368,085 | 0.0% |
| Ritter Pharmaceuticals Inc | COM | 767836109 | $1.3K | 778,000 | 0.0% |
| Cardica Inc | COM | 14141R101 | $1.4K | 8,874,992 | 0.0% |
| Mela Sciences Inc | COM NEW | 55277R308 | $1.4K | 1,274,297 | 0.0% |
| RXI Pharmaceuticals Corp New | COM NEW | 74979C303 | $2.0K | 5,126,482 | 0.0% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $2.2K | 304,980 | 0.0% |
| Ampliphi Biosciences Corp | COM NEW | 03211P202 | $2.2K | 552,000 | 0.0% |
| Discovery Laboratories Inc N | COM NEW | 254668403 | $2.3K | 10,889,166 | 0.0% |
| Biodelivery Sciences Intl in(BDSIUSD)Call | COM | 09060J106 | $2.4K | 500,000 | 0.0% |
| Nexvet Biopharma PUB LTD Co | ORD SHS | G6503X109 | $2.5K | 721,595 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $2.9K | 166,875 | 0.0% |
| Titan Pharmaceuticals Inc de | COM NEW | 888314309 | $3.4K | 761,201 | 0.0% |
| Protalix Biotherapeutics Inc | COM | 74365A101 | $3.4K | 3,338,570 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $3.8K | 1,113,986 | 0.0% |
| Epirus Biopharmaceuticals in | COM | 29428P107 | $4.2K | 1,375,000 | 0.0% |
| Carbylan Therapeutics Inc | COM | 141384107 | $4.3K | 1,178,941 | 0.0% |
| Orasure Technologies Inc(OSUR) | COM | 68554V108 | $4.4K | 685,528 | 0.0% |
| Genocea Biosciences Inc | COM | 372427104 | $4.5K | 846,243 | 0.0% |
| Mediwound LTD | ORD SHS | M68830104 | $4.5K | 530,985 | 0.0% |
| Biolinerx LTD | SPONSORED ADR | 09071M106 | $4.6K | 3,500,000 | 0.0% |
| CAS MED SYS Inc | COM PAR $0.004 | 124769209 | $4.6K | 2,618,296 | 0.0% |
| Scynexis Inc | COM | 811292101 | $4.8K | 775,000 | 0.0% |
| Aegerion Pharmaceuticals IncCall | COM | 00767E102 | $5.1K | 500,000 | 0.0% |
| Dipexium Pharmaceuticals Inc | COM | 25456J104 | $5.2K | 465,978 | 0.0% |
| Anthera Pharmaceuticals Inc | COM NEW | 03674U201 | $5.4K | 1,154,674 | 0.0% |
| Novadaq Technologies IncCall | COM | 66987G102 | $6.4K | 500,000 | 0.0% |
| Tenax Therapeutics Inc | COM | 88032L100 | $6.5K | 1,968,631 | 0.0% |
| Contrafect Corp(CFRXEUR) | COM | 212326102 | $6.7K | 1,418,439 | 0.0% |
| Biota Pharmaceutials Inc | COM | 090694100 | $6.8K | 3,486,711 | 0.0% |
| Tonix Pharmaceuticals Hldg C | COM NEW | 890260201 | $6.8K | 890,748 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $7.5K | 235,870 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $7.9K | 4,175,216 | 0.0% |
| Syneron Medical LTD | ORD SHS | M87245102 | $8.1K | 1,055,221 | 0.0% |
| Spectranetics Corp | COM | 84760C107 | $8.5K | 565,079 | 0.0% |
| Cynapsus Therapeutics Inc | COM PAR NO PAR | 23257Y859 | $8.9K | 583,121 | 0.0% |
| Pernix Therapeutics Hldgs in | DEBT 4.250% 4/0 | 71426VAJ7 | $8.9K | 15,500,000 | 0.0% |
| Amag Pharmaceuticals Inc(AMAG) | COM | 00163U106 | $9.1K | 300,000 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $9.5K | 3,125,282 | 0.0% |
| Idera Pharmaceuticals Inc | COM NEW | 45168K306 | $9.6K | 3,094,745 | 0.0% |
| Alcobra LTD | SHS | M2239P109 | $9.8K | 1,557,106 | 0.0% |
| Endologix Inc | COM | 29266S106 | $9.9K | 1,000,000 | 0.0% |
| Paratek Pharmaceuticals Inc | COM | 699374302 | $10.1K | 530,283 | 0.0% |
| Valeant Pharmaceuticals IntlCall | COM | 91911K102 | $10.2K | 100,000 | 0.0% |
| Trevena Inc | COM | 89532E109 | $10.5K | 1,000,000 | 0.0% |
| Redhill Biopharma LTD | SPONSORED ADS | 757468103 | $10.7K | 829,906 | 0.0% |
| Horizon Pharma PLCCall | SHS | G4617B105 | $10.8K | 500,000 | 0.0% |
| Strongbridge Biopharma PLC | SHS USD | G85347105 | $10.9K | 1,656,705 | 0.0% |
| Derma Sciences Inc | COM PAR $.01 | 249827502 | $11.7K | 2,562,104 | 0.0% |
| QLT Inc | COM | 746927102 | $11.8K | 4,445,527 | 0.0% |